The metabolic and pharmacokinetic differences between species are relevant, and Phase 1 human safety trials have not been completed for BPC-157
But whats in these special intravenous injections and how often can you get IV therapy
FDA, DOH warn public vs unauthorized glutathione use The Food and Drug Administration (FDA) said it only approves glutathione products with indications related to the treatment of "cisplatin chemotherapy" in response to concerns regarding a reported fatality associated with the use of glutathione
It means we stop guessing and start measuring
BPC-157 (Body Protection Compound-157) is a 15-amino acid sequence, stable in gastric acid, that has been studied for its effects on tissue healing, angiogenesis, and gastrointestinal mucosal integrity
After 4 weeks at therapeutic doses, most users report 50-70% reduction in pain, significantly improved function, and ability to resume modified training or activities